Rekah Pharmaceutical Industry Ltd (REKA) — Cash Flow Reinvestment Rate
Rekah Pharmaceutical Industry Ltd (REKA) has a Cash Flow Reinvestment Rate of 0.40x as of December 2025, reinvesting ILA2.10 Million (capex ILA2.10 Million ) from operating cash flow of ILA5.27 Million. Explore Rekah Pharmaceutical Industry Ltd (REKA) reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Rekah Pharmaceutical Industry Ltd Cash Flow Reinvestment Rate (2002–2025)
Historical reinvestment intensity for Rekah Pharmaceutical Industry Ltd across 21 annual periods. Also explore Rekah Pharmaceutical Industry Ltd balance sheet assets for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Rekah Pharmaceutical Industry Ltd (2002–2025)
Year-by-year capital reinvestment analysis for Rekah Pharmaceutical Industry Ltd. For live market cap and broader valuation context, see REKA market cap overview.
| Year | Reinvestment Rate | Total Reinvested (ILA) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.58x | ILA7.47 Million | ILA12.95 Million | ILA7.03 Million | ▲ +73.1% |
| 2024 | 0.33x | ILA8.85 Million | ILA26.54 Million | ILA8.70 Million | ▼ -18.3% |
| 2023 | 0.41x | ILA11.57 Million | ILA28.35 Million | ILA11.49 Million | ▼ -24.0% |
| 2022 | 0.54x | ILA20.93 Million | ILA39.00 Million | ILA7.48 Million | ▼ -35.6% |
| 2021 | 0.83x | ILA17.65 Million | ILA21.17 Million | ILA13.99 Million | ▼ -58.2% |
| 2020 | 1.99x | ILA22.49 Million | ILA11.28 Million | ILA18.84 Million | ▲ +37.8% |
| 2019 | 1.45x | ILA49.05 Million | ILA33.91 Million | ILA45.40 Million | ▲ +60.1% |
| 2018 | 0.90x | ILA15.61 Million | ILA17.28 Million | ILA15.18 Million | ▲ +20.9% |
| 2017 | 0.75x | ILA17.77 Million | ILA23.80 Million | ILA16.48 Million | ▼ -37.0% |
| 2016 | 1.19x | ILA27.08 Million | ILA22.82 Million | ILA13.44 Million | ▼ -54.1% |
| 2015 | 2.59x | ILA15.02 Million | ILA5.81 Million | ILA13.15 Million | ▼ -84.2% |
| 2014 | 16.32x | ILA21.71 Million | ILA1.33 Million | ILA19.27 Million | ▲ +4180.1% |
| 2013 | 0.38x | ILA4.46 Million | ILA11.71 Million | ILA4.38 Million | ▼ -44.9% |
| 2012 | 0.69x | ILA9.82 Million | ILA14.18 Million | ILA9.82 Million | ▼ -40.8% |
| 2010 | 1.17x | ILA7.87 Million | ILA6.73 Million | ILA7.87 Million | ▲ +226.1% |
| 2009 | 0.36x | ILA9.33 Million | ILA26.03 Million | ILA9.33 Million | ▼ -78.0% |
| 2008 | 1.63x | ILA10.73 Million | ILA6.57 Million | ILA10.73 Million | ▲ +285.0% |
| 2007 | 0.42x | ILA5.28 Million | ILA12.45 Million | ILA5.28 Million | ▼ -74.4% |
| 2005 | 1.66x | ILA7.09 Million | ILA4.27 Million | ILA7.09 Million | ▲ +530.7% |
| 2004 | 0.26x | ILA4.70 Million | ILA17.87 Million | ILA4.70 Million | ▲ +20.9% |
| 2002 | 0.22x | ILA2.44 Million | ILA11.21 Million | ILA2.44 Million | — |